Multicentre, interventional, single-arm study protocol of telemonitored circadian rhythms and patient-reported outcomes for improving mFOLFIRINOX safety in patients with pancreatic cancer (MultiDom, NCT04263948).
Mohamed BouchahdaAyhan UlusakaryaAnne Thirot-BidaultAmal AttariRachel BossevotRichard TuligengaPascal HammelRené AdamFrancis A LéviPublished in: BMJ open (2023)
NCT04263948 and ID RCB-2019-A00566-51.